23 May 2013
Keywords: Optimer Pharma, Astellas, Dificlir, European launch, Milestone
Article | 11 June 2012
USA-Based Optimer Pharmaceuticals (Nasdaq: OPTR) says that it is set to receive 10 million euros ($12.5 million) in milestone payments from partner ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 June 2012
12 June 2012
© 2013 thepharmaletter.com